![Catherine Ley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Catherine Ley
Career history of Catherine Ley
Former positions of Catherine Ley
Companies | Position | Start | End |
---|---|---|---|
CollabRx, Inc. /Old/
![]() CollabRx, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care. For physicians, Collabrx provides sophisticated, yet intuitive decision support tools to help them rapidly and accurately determine which medical tests, therapies, and clinical trials should be considered in order to deliver the best possible care to their patients. For patients, CollabRx provides actionable and highly-credible information that can be shared with their oncologist in a form that supports collaborative decision making in determining a cancer treatment plan that is customized for them. For researchers, CollabRx provides a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor, and more importantly link specific subtypes to relevant treatments and ultimately patient clinical outcomes to drive the science and medicine forward. | Corporate Officer/Principal | - | 27/09/2012 |
PATH Drug Solutions | Corporate Officer/Principal | - | - |
Training of Catherine Ley
University of California, Berkeley | Doctorate Degree |
Stanford University | Graduate Degree |
Statistics
International
United States | 5 |
Operational
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Commercial Services | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
CollabRx, Inc. /Old/
![]() CollabRx, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care. For physicians, Collabrx provides sophisticated, yet intuitive decision support tools to help them rapidly and accurately determine which medical tests, therapies, and clinical trials should be considered in order to deliver the best possible care to their patients. For patients, CollabRx provides actionable and highly-credible information that can be shared with their oncologist in a form that supports collaborative decision making in determining a cancer treatment plan that is customized for them. For researchers, CollabRx provides a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor, and more importantly link specific subtypes to relevant treatments and ultimately patient clinical outcomes to drive the science and medicine forward. | Commercial Services |
PATH Drug Solutions | Commercial Services |
- Stock Market
- Insiders
- Catherine Ley
- Experience